What is Immunovant Inc (IMVT)?
Immunovant Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for autoimmune diseases. The company concentrates on discovering and advancing treatments that target the underlying causes of immune system disorders. Its research and development efforts include the investigation of novel biologic agents designed to modulate immune responses. Immunovant aims to address conditions characterized by chronic inflammation and immune dysregulation. The company operates within the biotechnology sector, emphasizing innovation in therapeutic approaches for diseases with significant unmet medical needs. Its pipeline includes candidates in various stages of clinical evaluation, reflecting a commitment to advancing new treatment options.
Immunovant Inc Stock Price Today: Live Overview
The price today is shaped by current trading conditions for Immunovant Inc, priced at $23.05. The stock has fluctuated between $22.74 and $23.86, with a daily percentage move of 0%.
FAQ: Immunovant Inc (IMVT)
What is the current price of IMVT stock?
The current price stands at $23.05.
Does IMVT pay dividends?
Immunovant Inc does not pay dividends.
Does IMVT have a formal corporate presence or regional headquarters in the UAE?
Immunovant Inc does not have an official presence in the UAE and operates through distributors only.
What is IMVT best known for?
Immunovant Inc is most famous for developing therapies targeting autoimmune diseases.
What assets are typically shown together with IMVT?
Commonly shown alongside IMVT: Lenz Therapeutics Inc, Codexis, Travere Therapeutics, Inc.
Latest shares articles



